Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

The U.S. and Europe Are Shattering Coronavirus Records In The Third Wave

By The Daily Upside - Oct 26, 2020 at 8:49AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

But there is a silver lining

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter.  It's completely free and we guarantee you'll learn something new every day.

Whether you call it a third wave, a continuation of the first wave, or a by-product of pandemic fatigue, coronavirus is roaring back.

Let's take a look at the latest news surrounding the pandemic.

healthy living

Image Credit: Getty Images.

Case Climax
Starting with the bad news.

Stateside: Yesterday, the seven-day average of new cases hit 69k, topping the prior peak of 67k from over the summer. Hospitalizations are at their highest level in two months, according to the COVID Tracking Project.

Europe: New cases have exploded past previous highs, and officials are pumping the breaks on reopening:  

  • Ireland became the first EU country to reenter full, "Level 5" lockdown last week.  All non-essential retailers will be closed and 150,000 people are expected to lose their jobs "within days."  Residents have been told to stay home, and police will continue to use road checkpoints to deter non-essential travel.   
  • Italy tallied a record number of new cases this weekend and Prime Minister Giuseppe Conte has tightened restrictions in hopes of avoiding a heavy lockdown.  Gyms, pools, and movie theaters will be shuttered, and restaurants will be forced to close by 6 P.M. 

For Note: Earlier this month, the World Health Organization warned that national lockdowns should be used only as a "very, very last resort."

Solutions Brewing
Time for some good news.

Mortality Rates: The Surgeon General has said the U.S. mortality rate has dropped roughly 85% thanks to the effective use of steroids, the recently approved remdesivir (now branded as Veklury), and better management of patients.  

Vaccine: Vaccine efforts also got back on track on Friday. AstraZeneca and Johnson & Johnson got the go-ahead to resume their pivotal COVID-19 trials after regulators found no link between their shots and illnesses in a few trial participants.

The Takeaway: Experts caution a vaccine will not bring a "fairytale" ending to the pandemic, but it'll be a step in the right direction. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/08/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.